| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Microbiology-Immunology and
Pathology and the Interdepartmental Immunobiology Center, Northwestern University Medical School and the Northwestern University Institute for Neuroscience, Chicago, IL 60611;
Ben May Institute for Cancer Research and the Committee for Immunology, University of Chicago, Chicago, IL 60637; and
§
Immunology Research Division, Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115
The B7/CD28 pathway provides critical costimulatory signals
required for complete T cell activation and has served as a potential
target for immunotherapeutic strategies designed to regulate autoimmune
diseases. This study was designed to examine the roles of CD28 and its
individual ligands, B7-1 and B7-2, in experimental autoimmune
encephalomyelitis (EAE), a Th1-mediated inflammatory disease of the
CNS. EAE induction in CD28- or B7-deficient nonobese diabetic (NOD)
mice was compared with the effects of B7/CD28 blockade using Abs in
wild-type NOD mice. Disease severity was significantly reduced in
CD28-deficient as well as anti-B7-1/B7-2-treated NOD mice. B7-2
appeared to play the more dominant role as there was a moderate
decrease in disease incidence and severity in B7-2-deficient animals.
EAE resistance was not due to the lack of effective priming of the
myelin peptide-specific T cells in vivo. T cells isolated from
CD28-deficient animals produced equivalent amounts of IFN-
and
TNF-
in response to the immunogen, proteolipid protein 56–70. In
fact, IFN- and TNF- production by Ag-specific T cells was
enhanced in both the B7-1 and B7-2-deficient NOD mice. In contrast,
peptide-specific delayed-type hypersensitivity responses in these
animals were significantly decreased, suggesting a critical role for
CD28 costimulation in in vivo trafficking and systemic immunity.
Collectively, these results support a critical role for CD28
costimulation in EAE induction.
This article has been cited by other articles:
|
|
 |
|
  M. Pierau, S. Engelmann, D. Reinhold, T. Lapp, B. Schraven, and U. H. Bommhardt Protein Kinase B/Akt Signals Impair Th17 Differentiation and Support Natural Regulatory T Cell Function and Induced Regulatory T Cell Formation J. Immunol., November 15, 2009; 183(10): 6124 - 6134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. David, L. Ma, A. Ivetic, A. Takesono, A. J. Ridley, J.-G. Chai, V. L. Tybulewicz, and F. M. Marelli-Berg T-cell receptor- and CD28-induced Vav1 activity is required for the accumulation of primed T cells into antigenic tissue Blood, April 16, 2009; 113(16): 3696 - 3705. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Kim, C.-G. Jung, M. A. Jensen, D. Dukala, and B. Soliven Targeting of Myelin Protein Zero in a Spontaneous Autoimmune Polyneuropathy J. Immunol., December 15, 2008; 181(12): 8753 - 8760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Wolchok and Y. Saenger The Mechanism of Anti-CTLA-4 Activity and the Negative Regulation of T-Cell Activation Oncologist, October 1, 2008; 13(suppl_4): 2 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Perez, S. Karumuthil-Melethil, R. Li, B. S. Prabhakar, M. J. Holterman, and C. Vasu Preferential Costimulation by CD80 Results in IL-10-Dependent TGF-{beta}1+-Adaptive Regulatory T Cell Generation J. Immunol., May 15, 2008; 180(10): 6566 - 6576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Bour-Jordan, B. L. Salomon, H. L. Thompson, R. Santos, A. K. Abbas, and J. A. Bluestone Constitutive Expression of B7-1 on B Cells Uncovers Autoimmunity toward the B Cell Compartment in the Nonobese Diabetic Mouse J. Immunol., July 15, 2007; 179(2): 1004 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Khan, S. Ghousunnissa, S. M. Jegadeeswaran, D. Thiagarajan, S. E. Hasnain, and S. Mukhopadhyay Anti-B7-1/B7-2 antibody elicits innate-effector responses in macrophages through NF-{kappa}B-dependent pathway Int. Immunol., April 1, 2007; 19(4): 477 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Mirenda, S. J. Jarmin, R. David, J. Dyson, D. Scott, Y. Gu, R. I. Lechler, K. Okkenhaug, and F. M. Marelli-Berg Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28 Blood, April 1, 2007; 109(7): 2968 - 2977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nicolo, G. Di Sante, M. Orsini, S. Rolla, S. Columba-Cabezas, V. R. Spica, G. Ricciardi, B. M. C. Chan, and F. Ria Mycobacterium tuberculosis in the adjuvant modulates the balance of Th immune response to self-antigen of the CNS without influencing a "core" repertoire of specific T cells Int. Immunol., February 1, 2006; 18(2): 363 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Odobasic, A. R. Kitching, T. J. Semple, J. R. Timoshanko, P. G. Tipping, and S. R. Holdsworth Glomerular Expression of CD80 and CD86 Is Required for Leukocyte Accumulation and Injury in Crescentic Glomerulonephritis J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2012 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Davidson, B Diamond, D Wofsy, and D Daikh Block and tackle: CTLA4Ig takes on lupus Lupus, March 1, 2005; 14(3): 197 - 203. [Abstract] [PDF]
|
|
|
|
|
|
V. Taneja, N. Taneja, M. Behrens, M. M. Griffiths, H. S. Luthra, and C. S. David Requirement for CD28 May Not Be Absolute for Collagen-Induced Arthritis: Study with HLA-DQ8 Transgenic Mice J. Immunol., January 15, 2005; 174(2): 1118 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Karlsson, M. Johannesson, T. Lindvall, P. Wernhoff, R. Holmdahl, and A. Andersson Genetic Interactions in Eae2 Control Collagen-Induced Arthritis and the CD4+/CD8+ T Cell Ratio J. Immunol., January 1, 2005; 174(1): 533 - 541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rummel, J. Batchelder, P. Flaherty, G. LaFleur, P. Nanavati, J. M. Burns, and W. P. Weidanz CD28 Costimulation Is Required for the Expression of T-Cell-Dependent Cell-Mediated Immunity against Blood-Stage Plasmodium chabaudi Malaria Parasites Infect. Immun., October 1, 2004; 72(10): 5768 - 5774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yadav, V. Judkowski, M. Flodstrom-Tullberg, L. Sterling, W. L. Redmond, L. Sherman, and N. Sarvetnick B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets J. Immunol., September 15, 2004; 173(6): 3631 - 3639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wulff, H.-G. Knaus, M. Pennington, and K. G. Chandy K+ Channel Expression during B Cell Differentiation: Implications for Immunomodulation and Autoimmunity J. Immunol., July 15, 2004; 173(2): 776 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Greve, L. Vijayakrishnan, A. Kubal, R. A. Sobel, L. B. Peterson, L. S. Wicker, and V. K. Kuchroo The Diabetes Susceptibility Locus Idd5.1 on Mouse Chromosome 1 Regulates ICOS Expression and Modulates Murine Experimental Autoimmune Encephalomyelitis J. Immunol., July 1, 2004; 173(1): 157 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Bell, B. Min, R. K. Gregg, H.-H. Lee, and H. Zaghouani Break of Neonatal Th1 Tolerance and Exacerbation of Experimental Allergic Encephalomyelitis by Interference with B7 Costimulation J. Immunol., August 15, 2003; 171(4): 1801 - 1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Salama, T. Chitnis, J. Imitola, M. J. I. Ansari, H. Akiba, F. Tushima, M. Azuma, H. Yagita, M. H. Sayegh, and S. J. Khoury Critical Role of the Programmed Death-1 (PD-1) Pathway in Regulation of Experimental Autoimmune Encephalomyelitis J. Exp. Med., July 7, 2003; 198(1): 71 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pearson, T. G. Markees, L. S. Wicker, D. V. Serreze, L. B. Peterson, J. P. Mordes, A. A. Rossini, and D. L. Greiner NOD Congenic Mice Genetically Protected From Autoimmune Diabetes Remain Resistant to Transplantation Tolerance Induction Diabetes, February 1, 2003; 52(2): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Pilon, C. Kelly, and W.-Z. Wei Broadening of Epitope Recognition During Immune Rejection of ErbB-2-Positive Tumor Prevents Growth of ErbB-2-Negative Tumor J. Immunol., February 1, 2003; 170(3): 1202 - 1208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Haspot, F. Villemain, G. Laflamme, F. Coulon, D. Olive, J. Tiollier, J.-P. Soulillou, and B. Vanhove Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses Blood, March 15, 2002; 99(6): 2228 - 2234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Compton and J. P. Farrell CD28 Costimulation and Parasite Dose Combine to Influence the Susceptibility of BALB/c Mice to Infection with Leishmania major J. Immunol., February 1, 2002; 168(3): 1302 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Salomon, L. Rhee, H. Bour-Jordan, H. Hsin, A. Montag, B. Soliven, J. Arcella, A. M. Girvin, S. D. Miller, and J. A. Bluestone Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2-Deficient Nod Mice J. Exp. Med., September 3, 2001; 194(5): 677 - 684. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Ndhlovu, N. Ishii, K. Murata, T. Sato, and K. Sugamura Critical Involvement of OX40 Ligand Signals in the T Cell Priming Events During Experimental Autoimmune Encephalomyelitis J. Immunol., September 1, 2001; 167(5): 2991 - 2999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. H. Chung, I. M. Belyakov, M. A. Derby, J. Wang, L. F. Boyd, J. A. Berzofsky, and D. H. Margulies Competitive Inhibition In Vivo and Skewing of the T Cell Repertoire of Antigen-Specific CTL Priming by an Anti-Peptide-MHC Monoclonal Antibody J. Immunol., July 15, 2001; 167(2): 699 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Donepudi, P. Raychaudhuri, J. A. Bluestone, and M. B. Mokyr Mechanism of Melphalan-Induced B7-1 Gene Expression in P815 Tumor Cells J. Immunol., June 1, 2001; 166(11): 6491 - 6499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Markiewicz, F. Fallarino, A. Ashikari, and T. F. Gajewski Epitope spreading upon P815 tumor rejection triggered by vaccination with the single class I MHC-restricted peptide P1A Int. Immunol., May 1, 2001; 13(5): 625 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Pal, T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura Costimulation-Dependent Modulation of Experimental Autoimmune Encephalomyelitis by Ligand Stimulation of V{{alpha}}14 NK T Cells J. Immunol., January 1, 2001; 166(1): 662 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Silver, K. S. Hathcock, C.-C. Chan, B. Wiggert, and R. R. Caspi Blockade of Costimulation Through B7/CD28 Inhibits Experimental Autoimmune Uveoretinitis, But Does Not Induce Long-Term Tolerance J. Immunol., November 1, 2000; 165(9): 5041 - 5047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Neville, M. C. Dal Canto, J. A. Bluestone, and S. D. Miller CD28 Costimulatory Blockade Exacerbates Disease Severity and Accelerates Epitope Spreading in a Virus-Induced Autoimmune Disease J. Virol., September 15, 2000; 74(18): 8349 - 8357. [Abstract] [Full Text]
|
|
|
|
|
|
D. K. Sojka, M. Donepudi, J. A. Bluestone, and M. B. Mokyr Melphalan and Other Anticancer Modalities Up-Regulate B7-1 Gene Expression in Tumor Cells J. Immunol., June 15, 2000; 164(12): 6230 - 6236. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
